Related Experiment Video
Updated: Dec 22, 2025

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
Analysis of Drug Effects on iPSC Cardiomyocytes with Machine Learning.
Martti Juhola1, Kirsi Penttinen2, Henry Joutsijoki3
1Faculty of Information Technology and Communication Sciences, Tampere University, Tampere, Finland. Martti.Juhola@tuni.fi.
Machine learning analyzes patient-specific stem cell-derived cardiomyocytes (iPSC-CMs) to predict drug effects for inherited heart conditions like CPVT. This approach shows promise for personalized medicine and efficient drug screening.
Area of Science:
- Cardiology
- Stem Cell Biology
- Artificial Intelligence in Medicine
Background:
- Patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) are valuable for studying cardiac diseases.
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe inherited arrhythmogenic disorder.
- Machine learning (ML) offers advanced analytical capabilities for complex biological data.
Purpose of the Study:
- To utilize iPSC-CMs and ML to analyze calcium transient signals and assess drug effects.
- To investigate the antiarrhythmic effect of dantrolene in iPSC-CMs from CPVT patients.
- To evaluate the efficacy of ML in classifying drug responses in iPSC-CMs.
Main Methods:
- Developed a peak recognition algorithm to identify transient signals in iPSC-CMs.
- Computed 12 peak variables from identified signals for classification.
- Employed ML to classify signals based on adrenaline stimulation and dantrolene treatment.
Main Results:
- Successfully identified and analyzed calcium transient signals in iPSC-CMs.
- Achieved a classification accuracy of approximately 79% for drug effect prediction.
- Demonstrated the utility of ML in analyzing iPSC-CM drug responses.
Conclusions:
- ML methods are effective for analyzing iPSC-CM drug effects.
- This approach can facilitate personalized medication strategies for cardiac conditions.
- Future applications include efficient drug screening and cardiotoxicity studies.
More Related Videos
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018